Michele C. Livesey,
MBA

Ms. Livesey brings to DIA more than two decades of drug development experience through managing and leading strategy and drug development projects for Genentech, Inc., Barrier Therapeutics, Roche, and Afferent Pharmaceuticals. She has worked on monoclonal antibodies and small molecules in all stages of drug development through commercialization, including collaborations with international partners; her therapeutic experience includes oncology, dermatology, cardiovascular, virology, immunology, and pain. Ms. Livesey is Founder and President of Livesey Consulting, which is focused on helping companies reach important drug development milestones and build and execute strategies. She previously served as Vice President of Development Operations for Afferent Pharmaceuticals, where she was responsible for the staffing and oversight of non-clinical (toxicology, and drug metabolism and pharmacokinetics), chemistry, manufacturing and controls, regulatory, quality assurance, project management, and general business operations.

Ms. Livesey has served DIA for more than a decade as an Annual Meeting speaker, session chair, and track chair, and has also provided leadership to the DIA Project Management Community. Ms. Livesey earned her Masters of Business Administration with honors from Golden Gate University with an emphasis in Marketing and Operations and Supply Chain Management.